Medtronic ROA 2006-2020 | MDT
Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Medtronic ROA for the three months ending April 30, 2020 was 6.79%.
| Medtronic ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2020-04-30 | $4.79B | $90.69B | 5.24% |
| 2020-01-31 | $5.32B | $92.82B | 5.83% |
| 2019-10-31 | $4.67B | $91.05B | 5.18% |
| 2019-07-31 | $4.42B | $91.27B | 4.94% |
| 2019-04-30 | $4.63B | $89.69B | 5.20% |
| 2019-01-31 | $4.92B | $88.73B | 5.50% |
| 2018-10-31 | $2.26B | $88.15B | 2.48% |
| 2018-07-31 | $3.16B | $89.72B | 3.41% |
| 2018-04-30 | $3.10B | $91.39B | 3.25% |
| 2018-01-31 | $2.81B | $95.80B | 2.88% |
| 2017-10-31 | $5.02B | $94.46B | 5.12% |
| 2017-07-31 | $4.12B | $100.25B | 4.16% |
| 2017-04-30 | $4.03B | $99.86B | 4.08% |
| 2017-01-31 | $3.97B | $97.58B | 4.03% |
| 2016-10-31 | $4.24B | $98.41B | 4.25% |
| 2016-07-31 | $3.65B | $98.60B | 3.59% |
| 2016-04-30 | $3.54B | $99.64B | 3.44% |
| 2016-01-31 | $2.43B | $102.71B | 2.32% |
| 2015-10-31 | $2.32B | $104.95B | 2.49% |
| 2015-07-31 | $2.62B | $104.63B | 3.44% |
| 2015-04-30 | $2.68B | $106.69B | 4.49% |
| 2015-01-31 | $3.12B | $55.23B | 7.37% |
| 2014-10-31 | $2.91B | $38.78B | 7.68% |
| 2014-07-31 | $2.98B | $37.55B | 8.00% |
| 2014-04-30 | $3.07B | $37.94B | 8.36% |
| 2014-01-31 | $3.59B | $37.23B | 9.99% |
| 2013-10-31 | $3.81B | $36.47B | 10.79% |
| 2013-07-31 | $3.56B | $34.97B | 10.25% |
| 2013-04-30 | $3.47B | $34.90B | 10.12% |
| 2013-01-31 | $3.49B | $34.95B | 10.34% |
| 2012-10-31 | $3.44B | $33.96B | 10.41% |
| 2012-07-31 | $3.66B | $33.25B | 11.28% |
| 2012-04-30 | $3.62B | $32.82B | 11.34% |
| 2012-01-31 | $3.40B | $31.91B | 10.85% |
| 2011-10-31 | $3.39B | $31.75B | 10.93% |
| 2011-07-31 | $3.09B | $31.09B | 10.15% |
| 2011-04-30 | $3.10B | $30.68B | 10.39% |
| 2011-01-31 | $3.28B | $30.60B | 11.23% |
| 2010-10-31 | $3.18B | $29.31B | 11.44% |
| 2010-07-31 | $3.48B | $28.66B | 13.12% |
| 2010-04-30 | $3.10B | $28.09B | 12.26% |
| 2010-01-31 | $2.25B | $25.17B | 9.30% |
| 2009-10-31 | $2.11B | $24.28B | 8.97% |
| 2009-07-31 | $1.79B | $23.57B | 7.79% |
| 2009-04-30 | $2.07B | $23.59B | 9.09% |
| 2009-01-31 | $2.69B | $22.76B | 11.98% |
| 2008-10-31 | $2.07B | $22.03B | 9.36% |
| 2008-07-31 | $2.19B | $22.73B | 10.06% |
| 2008-04-30 | $2.14B | $22.20B | 10.20% |
| 2008-01-31 | $2.23B | $21.41B | 10.99% |
| 2007-10-31 | $2.86B | $20.59B | 14.44% |
| 2007-07-31 | $2.88B | $19.66B | 14.83% |
| 2007-04-30 | $2.80B | $19.51B | 14.34% |
| 2007-01-31 | $2.73B | $19.57B | 13.94% |
| 2006-10-31 | $2.69B | $18.90B | 13.95% |
| 2006-07-31 | $2.83B | $20.18B | 14.88% |
| 2006-04-30 | $2.55B | $19.67B | 14.02% |
| 2006-01-31 | $2.00B | $18.34B | 11.50% |
| 2005-10-31 | $1.88B | $17.77B | 11.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $129.154B | $28.913B |
| Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.761B | 33.20 |
| Stryker (SYK) | United States | $70.955B | 27.51 |
| Boston Scientific (BSX) | United States | $51.986B | 30.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.178B | 0.00 |
| Baxter (BAX) | United States | $41.045B | 25.10 |
| Terumo (TRUMY) | Japan | $29.530B | 37.75 |
| ResMed (RMD) | United States | $29.334B | 46.29 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.492B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.965B | 22.45 |
| Sunny Optical Technology (SNPTF) | China | $20.566B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.585B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.620B | 70.72 |
| Insulet (PODD) | United States | $13.019B | 1289.81 |
| Quidel (QDEL) | United States | $12.525B | 66.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.849B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| Perrigo (PRGO) | Ireland | $7.514B | 13.44 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.165B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.311B | 15.66 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.203B | 0.00 |
| Neogen (NEOG) | United States | $4.135B | 69.10 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.995B | 0.00 |
| Haemonetics (HAE) | United States | $3.842B | 25.80 |
| ICU Medical (ICUI) | United States | $3.834B | 27.97 |
| Envista Holdings (NVST) | United States | $3.641B | 24.83 |
| Abcam (ABCZY) | $3.406B | 0.00 | |
| Agios Pharmaceuticals (AGIO) | United States | $3.048B | 0.00 |
| NuVasive (NUVA) | United States | $2.754B | 38.38 |
| National Vision Holdings (EYE) | United States | $2.703B | 46.76 |
| TG Therapeutics (TGTX) | United States | $2.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.706B | 157.08 |
| MacroGenics (MGNX) | United States | $1.438B | 0.00 |
| Aphria (APHA) | Canada | $1.408B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.239B | 0.00 |
| Cerus (CERS) | United States | $1.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.197B | 241.13 |
| Vapotherm (VAPO) | United States | $1.124B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.091B | 41.06 |
| Cardiovascular Systems (CSII) | United States | $1.086B | 0.00 |
| PetIQ (PETQ) | United States | $1.062B | 30.68 |
| InMode (INMD) | Israel | $1.053B | 22.24 |
| Owens & Minor (OMI) | United States | $1.047B | 23.74 |
| Phibro Animal Health (PAHC) | United States | $0.951B | 18.96 |
| Quanterix (QTRX) | United States | $0.934B | 0.00 |
| Omeros (OMER) | United States | $0.714B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.670B | 190.82 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.659B | 47.18 |
| Surmodics (SRDX) | United States | $0.640B | 77.15 |
| VAREX IMAGING (VREX) | United States | $0.636B | 15.80 |
| Zynex (ZYXI) | United States | $0.626B | 54.70 |
| LeMaitre Vascular (LMAT) | United States | $0.595B | 36.42 |
| Lantheus Holdings (LNTH) | United States | $0.503B | 11.72 |
| Viemed Healthcare (VMD) | United States | $0.434B | 38.48 |
| Cytosorbents (CTSO) | United States | $0.341B | 0.00 |
| HEXO (HEXO) | $0.338B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.331B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.295B | 25.33 |
| InfuSystems Holdings (INFU) | United States | $0.256B | 141.56 |
| Organigram Holdings (OGI) | Canada | $0.228B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.177B | 0.00 |
| Bovie Medical (APYX) | United States | $0.168B | 0.00 |
| Fonar (FONR) | United States | $0.161B | 14.24 |
| Surface Oncology (SURF) | United States | $0.159B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.149B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.128B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.126B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.124B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.115B | 0.00 |
| Evolus (EOLS) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.089B | 0.00 |
| Nephros (NEPH) | United States | $0.076B | 0.00 |
| United-Guardian (UG) | United States | $0.072B | 16.78 |
| Brainsway (BWAY) | Israel | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.031B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.028B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
